Connection

ARNOLD DELA CRUZ PAULINO to Female

This is a "connection" page, showing publications ARNOLD DELA CRUZ PAULINO has written about Female.
Connection Strength

0.965
  1. The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma. Neuro Oncol. 2024 Oct 03; 26(10):1912-1920.
    View in: PubMed
    Score: 0.027
  2. Late-onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly diagnosed pediatric medulloblastoma. Pediatr Blood Cancer. 2024 Jul; 71(7):e31022.
    View in: PubMed
    Score: 0.026
  3. Comprehensive radiotherapy for pediatric Ewing Sarcoma: Outcomes of a prospective proton study. Radiother Oncol. 2024 06; 195:110270.
    View in: PubMed
    Score: 0.026
  4. Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors. Neuro Oncol. 2022 09 01; 24(9):1571-1581.
    View in: PubMed
    Score: 0.023
  5. Scoliosis in Children Treated With Photon Craniospinal Irradiation for Medulloblastoma. Int J Radiat Oncol Biol Phys. 2021 03 01; 109(3):712-717.
    View in: PubMed
    Score: 0.021
  6. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2021 03 01; 109(3):718-725.
    View in: PubMed
    Score: 0.021
  7. Training and education of pediatric radiation oncologists: A survey from the 2019 Pediatric Radiation Oncology Society meeting. Pediatr Blood Cancer. 2020 10; 67(10):e28619.
    View in: PubMed
    Score: 0.020
  8. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma. Pediatr Blood Cancer. 2019 11; 66(11):e27952.
    View in: PubMed
    Score: 0.019
  9. Efficacy of proton therapy in children with high-risk and locally recurrent neuroblastoma. Pediatr Blood Cancer. 2019 08; 66(8):e27786.
    View in: PubMed
    Score: 0.019
  10. Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma. Radiother Oncol. 2019 05; 134:143-150.
    View in: PubMed
    Score: 0.018
  11. Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma. Pediatr Blood Cancer. 2018 08; 65(8):e27095.
    View in: PubMed
    Score: 0.017
  12. Radiation pneumonitis in pediatric Hodgkin lymphoma patients receiving radiation therapy to the chest. Pract Radiat Oncol. 2018 Sep - Oct; 8(5):e364-e368.
    View in: PubMed
    Score: 0.017
  13. Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy. Radiother Oncol. 2018 07; 128(1):128-132.
    View in: PubMed
    Score: 0.017
  14. Local therapy to distant metastatic sites in stage IV rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Feb; 65(2).
    View in: PubMed
    Score: 0.017
  15. Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma. Radiother Oncol. 2015 Feb; 114(2):224-9.
    View in: PubMed
    Score: 0.014
  16. Comparison of supine and prone craniospinal irradiation in children with medulloblastoma. Pract Radiat Oncol. 2015 Mar-Apr; 5(2):93-8.
    View in: PubMed
    Score: 0.013
  17. Radiotherapy in metastatic ewing sarcoma. Am J Clin Oncol. 2013 Jun; 36(3):283-6.
    View in: PubMed
    Score: 0.012
  18. Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma. Cancer. 2013 Jul 15; 119(14):2654-9.
    View in: PubMed
    Score: 0.012
  19. Rhabdomyosarcoma arising in a previously irradiated field: an analysis of 43 patients. Int J Radiat Oncol Biol Phys. 2013 Mar 01; 85(3):598-603.
    View in: PubMed
    Score: 0.012
  20. Outcome of patients with pilocytic astrocytoma and leptomeningeal dissemination. Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):350-4.
    View in: PubMed
    Score: 0.011
  21. Bifocal intracranial germinoma: a retrospective analysis of treatment outcomes in 20 patients and review of the literature. Int J Radiat Oncol Biol Phys. 2012 Mar 15; 82(4):1341-51.
    View in: PubMed
    Score: 0.011
  22. Characteristics and outcome of radiation and chemotherapy-related mucoepidermoid carcinoma of the salivary glands. Pediatr Blood Cancer. 2011 Dec 15; 57(7):1137-41.
    View in: PubMed
    Score: 0.010
  23. Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma. Cancer. 2011 Feb 01; 117(3):635-41.
    View in: PubMed
    Score: 0.010
  24. Height impairment after lower dose cranial irradiation in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2011 Feb; 56(2):279-81.
    View in: PubMed
    Score: 0.010
  25. Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. Int J Radiat Oncol Biol Phys. 2010 Dec 01; 78(5):1445-50.
    View in: PubMed
    Score: 0.010
  26. Prognostic factors after extraneural metastasis of medulloblastoma. Int J Radiat Oncol Biol Phys. 2010 Sep 01; 78(1):72-8.
    View in: PubMed
    Score: 0.010
  27. Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk? Pediatr Blood Cancer. 2009 Dec 15; 53(7):1332-3.
    View in: PubMed
    Score: 0.010
  28. The influence of pretreatment characteristics and radiotherapy parameters on time interval to development of radiation-associated meningioma. Int J Radiat Oncol Biol Phys. 2009 Dec 01; 75(5):1408-14.
    View in: PubMed
    Score: 0.009
  29. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):173-7.
    View in: PubMed
    Score: 0.009
  30. Intensity-modulated radiation therapy in childhood ependymoma. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):987-93.
    View in: PubMed
    Score: 0.009
  31. Supine craniospinal irradiation using intrafractional junction shifts and field-in-field dose shaping: early experience at Methodist Hospital. Int J Radiat Oncol Biol Phys. 2008 Jun 01; 71(2):477-83.
    View in: PubMed
    Score: 0.008
  32. Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma. Pediatr Blood Cancer. 2007 Aug; 49(2):145-8.
    View in: PubMed
    Score: 0.008
  33. An analysis of primary site control and late effects according to local control modality in non-metastatic Ewing sarcoma. Pediatr Blood Cancer. 2007 Apr; 48(4):423-9.
    View in: PubMed
    Score: 0.008
  34. Comparison of conventional to intensity modulated radiation therapy for abdominal neuroblastoma. Pediatr Blood Cancer. 2006 Jun; 46(7):739-44.
    View in: PubMed
    Score: 0.008
  35. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005 Apr 01; 61(5):1385-92.
    View in: PubMed
    Score: 0.007
  36. Risk factors for scoliosis in children with neuroblastoma. Int J Radiat Oncol Biol Phys. 2005 Mar 01; 61(3):865-9.
    View in: PubMed
    Score: 0.007
  37. Secondary neoplasms after radiotherapy for a childhood solid tumor. Pediatr Hematol Oncol. 2005 Mar; 22(2):89-101.
    View in: PubMed
    Score: 0.007
  38. The value of postoperative radiotherapy in childhood nonrhabdomyosarcoma soft tissue sarcoma. Pediatr Blood Cancer. 2004 Oct; 43(5):587-93.
    View in: PubMed
    Score: 0.007
  39. Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys. 2004 Sep 01; 60(1):265-74.
    View in: PubMed
    Score: 0.007
  40. Evolution of Proton Radiation Therapy Brainstem Constraints on the Pediatric Proton/Photon Consortium Registry. Pract Radiat Oncol. 2024 Nov-Dec; 14(6):e507-e514.
    View in: PubMed
    Score: 0.007
  41. Travel-Time Disparities in Access to Proton Beam Therapy for Cancer Treatment. JAMA Netw Open. 2024 May 01; 7(5):e2410670.
    View in: PubMed
    Score: 0.007
  42. Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534. Pediatr Blood Cancer. 2024 Jul; 71(7):e30981.
    View in: PubMed
    Score: 0.007
  43. Synovial sarcoma prognostic factors and patterns of failure. Am J Clin Oncol. 2004 Apr; 27(2):122-7.
    View in: PubMed
    Score: 0.007
  44. Patterns of failure in relation to radiotherapy fields in supratentorial primitive neuroectodermal tumor. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1171-6.
    View in: PubMed
    Score: 0.007
  45. Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2. Cancer. 2024 Jul 01; 130(13):2361-2371.
    View in: PubMed
    Score: 0.006
  46. Brain metastasis in children with sarcoma, neuroblastoma, and Wilms' tumor. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):177-83.
    View in: PubMed
    Score: 0.006
  47. Local control of parameningeal rhabdomyosarcoma: outcomes in non-complete responders to chemoradiation. Med Pediatr Oncol. 2003 Aug; 41(2):118-22.
    View in: PubMed
    Score: 0.006
  48. Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience. J Neurooncol. 2023 Jul; 163(3):717-726.
    View in: PubMed
    Score: 0.006
  49. Long-term survival in a child with extraneural metastasis from medulloblastoma treated with chemo-radiotherapy. Med Pediatr Oncol. 2003 Jun; 40(6):396-7.
    View in: PubMed
    Score: 0.006
  50. Palliative radiotherapy in children with neuroblastoma. Pediatr Hematol Oncol. 2003 Mar; 20(2):111-7.
    View in: PubMed
    Score: 0.006
  51. Impact of Age on Overall Survival Among Children With Wilms Tumor: A Population-based Registry Analysis. Am J Clin Oncol. 2023 05 01; 46(5):213-218.
    View in: PubMed
    Score: 0.006
  52. Comparison of neurocognitive and quality-of-life outcomes in pediatric craniopharyngioma patients treated with partial resection and radiotherapy versus gross-total resection only. J Neurosurg Pediatr. 2023 05 01; 31(5):453-462.
    View in: PubMed
    Score: 0.006
  53. Protracted radiotherapy treatment duration in medulloblastoma. Am J Clin Oncol. 2003 Feb; 26(1):55-9.
    View in: PubMed
    Score: 0.006
  54. Development and validation of a population-based anatomical colorectal model for radiation dosimetry in late effects studies of survivors of childhood cancer. Radiother Oncol. 2022 11; 176:118-126.
    View in: PubMed
    Score: 0.006
  55. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Int J Radiat Oncol Biol Phys. 2002 Jul 01; 53(3):543-7.
    View in: PubMed
    Score: 0.006
  56. Predicting neurocognitive function in pediatric brain tumor early survivorship: The neurological predictor scale and the incremental validity of tumor size. Pediatr Blood Cancer. 2022 09; 69(9):e29803.
    View in: PubMed
    Score: 0.006
  57. Intracranial ependymomas: an analysis of prognostic factors and patterns of failure. Am J Clin Oncol. 2002 Apr; 25(2):117-22.
    View in: PubMed
    Score: 0.006
  58. Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity. Int J Radiat Oncol Biol Phys. 2002 Mar 15; 52(4):1025-31.
    View in: PubMed
    Score: 0.006
  59. Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis: A Report from the Children's Oncology Group Study AREN0534. Ann Surg Oncol. 2022 May; 29(5):3252-3261.
    View in: PubMed
    Score: 0.006
  60. Intensity-modulated radiation therapy in the treatment of children. Med Dosim. 2002; 27(2):115-20.
    View in: PubMed
    Score: 0.006
  61. Amiodarone and radiation therapy sequelae. Am J Clin Oncol. 2001 Aug; 24(4):379-81.
    View in: PubMed
    Score: 0.005
  62. Relapsed Wilms tumor: is there a role for radiation therapy? Am J Clin Oncol. 2001 Aug; 24(4):408-13.
    View in: PubMed
    Score: 0.005
  63. Long-term cognitive and academic outcomes among pediatric brain tumor survivors treated with proton versus photon radiotherapy. Pediatr Blood Cancer. 2021 09; 68(9):e29125.
    View in: PubMed
    Score: 0.005
  64. Case series of diffuse extraneural metastasis in H3F3A mutant high-grade gliomas: Clinical, molecular phenotype and literature review. J Clin Neurosci. 2021 Jul; 89:405-411.
    View in: PubMed
    Score: 0.005
  65. The local field in infratentorial ependymoma: does the entire posterior fossa need to be treated? Int J Radiat Oncol Biol Phys. 2001 Mar 01; 49(3):757-61.
    View in: PubMed
    Score: 0.005
  66. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. J Clin Oncol. 2021 03 01; 39(7):807-821.
    View in: PubMed
    Score: 0.005
  67. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2000 Dec 01; 48(5):1489-95.
    View in: PubMed
    Score: 0.005
  68. Comparison of posterior fossa and tumor bed boost in medulloblastoma. Am J Clin Oncol. 2000 Oct; 23(5):487-90.
    View in: PubMed
    Score: 0.005
  69. Early evidence of pulmonary dysfunction in survivors of childhood Hodgkin lymphoma. Leuk Lymphoma. 2020 10; 61(10):2419-2427.
    View in: PubMed
    Score: 0.005
  70. The significance of radiotherapy treatment duration in intracranial ependymoma. Int J Radiat Oncol Biol Phys. 2000 Jun 01; 47(3):585-9.
    View in: PubMed
    Score: 0.005
  71. Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group. Cancer. 2020 08 01; 126(15):3516-3525.
    View in: PubMed
    Score: 0.005
  72. Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis. Pediatr Blood Cancer. 2020 08; 67(8):e28373.
    View in: PubMed
    Score: 0.005
  73. A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma. Pediatr Blood Cancer. 2020 06; 67(6):e28283.
    View in: PubMed
    Score: 0.005
  74. Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma. JAMA Ophthalmol. 2020 04 01; 138(4):374-381.
    View in: PubMed
    Score: 0.005
  75. Late effects in children treated with radiation therapy for Wilms' tumor. Int J Radiat Oncol Biol Phys. 2000 Mar 15; 46(5):1239-46.
    View in: PubMed
    Score: 0.005
  76. Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study. J Clin Oncol. 2020 05 10; 38(14):1558-1568.
    View in: PubMed
    Score: 0.005
  77. Unresectable adenocarcinoma of the pancreas: patterns of failure and treatment results. Cancer Invest. 2000; 18(4):309-13.
    View in: PubMed
    Score: 0.005
  78. Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors of pediatric embryonal brain tumor. J Neurooncol. 2020 Jan; 146(1):147-156.
    View in: PubMed
    Score: 0.005
  79. Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma. J Clin Oncol. 2020 02 10; 38(5):454-461.
    View in: PubMed
    Score: 0.005
  80. Cognitive mediators of adaptive functioning outcomes in survivors of pediatric brain tumors treated with proton radiotherapy. Pediatr Blood Cancer. 2020 02; 67(2):e28064.
    View in: PubMed
    Score: 0.005
  81. Malignant neoplasms after treatment for metachronous bilateral Wilms' tumor: a literature review. Pediatr Hematol Oncol. 1999 Nov-Dec; 16(6):533-8.
    View in: PubMed
    Score: 0.005
  82. An open invitation to join the Pediatric Proton/Photon Consortium Registry to standardize data collection in pediatric radiation oncology. Br J Radiol. 2020 Mar; 93(1107):20190673.
    View in: PubMed
    Score: 0.005
  83. Resected pancreatic cancer treated with adjuvant radiotherapy with or without 5-fluorouracil: treatment results and patterns of failure. Am J Clin Oncol. 1999 Oct; 22(5):489-94.
    View in: PubMed
    Score: 0.005
  84. Trilateral retinoblastoma: is the location of the intracranial tumor important? Cancer. 1999 Jul 01; 86(1):135-41.
    View in: PubMed
    Score: 0.005
  85. Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only. Neuro Oncol. 2019 06 10; 21(6):809-818.
    View in: PubMed
    Score: 0.005
  86. Diffuse malignant leptomeningeal gliomatosis in a child: a case report and review of the literature. Am J Clin Oncol. 1999 Jun; 22(3):243-6.
    View in: PubMed
    Score: 0.005
  87. Adaptive functioning in pediatric brain tumor survivors: An examination of ethnicity and socioeconomic status. Pediatr Blood Cancer. 2019 09; 66(9):e27800.
    View in: PubMed
    Score: 0.005
  88. Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy. Neuro Oncol. 2019 05 06; 21(5):686-695.
    View in: PubMed
    Score: 0.005
  89. The cranial-spinal junction in medulloblastoma: does it matter? Int J Radiat Oncol Biol Phys. 1999 Apr 01; 44(1):81-4.
    View in: PubMed
    Score: 0.005
  90. A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma. Int J Radiat Oncol Biol Phys. 2019 05 01; 104(1):144-148.
    View in: PubMed
    Score: 0.005
  91. Timing of Local Therapy Affects Survival in Ewing Sarcoma. Int J Radiat Oncol Biol Phys. 2019 05 01; 104(1):127-136.
    View in: PubMed
    Score: 0.005
  92. Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma. Pediatr Hematol Oncol. 2018 May; 35(4):257-267.
    View in: PubMed
    Score: 0.005
  93. Patterns of proton therapy use in pediatric cancer management in 2016: An international survey. Radiother Oncol. 2019 03; 132:155-161.
    View in: PubMed
    Score: 0.004
  94. Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors. J Clin Oncol. 2018 10 01; 36(28):2854-2862.
    View in: PubMed
    Score: 0.004
  95. Results of treatment of patients with maxillary sinus carcinoma. Cancer. 1998 Aug 01; 83(3):457-65.
    View in: PubMed
    Score: 0.004
  96. Prognostic Factors, Treatment, and Outcomes in Early Stage, Invasive Papillary Breast Cancer: A SEER Investigation of Less Aggressive Treatment in a Favorable Histology. Am J Clin Oncol. 2018 06; 41(6):532-537.
    View in: PubMed
    Score: 0.004
  97. Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study. J Clin Oncol. 2018 06 01; 36(16):1564-1570.
    View in: PubMed
    Score: 0.004
  98. Timing of Radiation Therapy in Pediatric Wilms Tumor: A Report From the National Cancer Database. Int J Radiat Oncol Biol Phys. 2018 06 01; 101(2):453-461.
    View in: PubMed
    Score: 0.004
  99. Regional Nodal Control for Head and Neck Alveolar Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):169-176.
    View in: PubMed
    Score: 0.004
  100. Metachronous bilateral Wilms' tumor: the importance of time interval to the development of a second tumor. Cancer. 1998 Jan 15; 82(2):415-20.
    View in: PubMed
    Score: 0.004
  101. Pediatric head and neck squamous cell carcinoma: Patient demographics, treatment trends and outcomes. Int J Pediatr Otorhinolaryngol. 2018 Mar; 106:21-25.
    View in: PubMed
    Score: 0.004
  102. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532. J Clin Oncol. 2018 01 20; 36(3):254-261.
    View in: PubMed
    Score: 0.004
  103. A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas. Pediatr Blood Cancer. 2018 Feb; 65(2).
    View in: PubMed
    Score: 0.004
  104. Is prophylactic neck irradiation indicated in patients with squamous cell carcinoma of the maxillary sinus? Int J Radiat Oncol Biol Phys. 1997 Sep 01; 39(2):283-9.
    View in: PubMed
    Score: 0.004
  105. Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group. Ann Surg. 2017 09; 266(3):470-478.
    View in: PubMed
    Score: 0.004
  106. Attention, processing speed, and executive functioning in pediatric brain tumor survivors treated with proton beam radiation therapy. Radiother Oncol. 2017 07; 124(1):89-97.
    View in: PubMed
    Score: 0.004
  107. Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy. Cancer. 2017 Jul 01; 123(13):2570-2578.
    View in: PubMed
    Score: 0.004
  108. Splenic irradiation in the palliation of patients with lymphoproliferative and myeloproliferative disorders. Am J Hosp Palliat Care. 1996 Nov-Dec; 13(6):32-5.
    View in: PubMed
    Score: 0.004
  109. Local control in synchronous bilateral Wilms tumor. Int J Radiat Oncol Biol Phys. 1996 Oct 01; 36(3):541-8.
    View in: PubMed
    Score: 0.004
  110. Postoperative irradiation of patients with malignant tumors of skull base. Laryngoscope. 1996 Jul; 106(7):880-3.
    View in: PubMed
    Score: 0.004
  111. Gemcitabine-induced radiation recall myositis in a patient with relapsed nasopharyngeal carcinoma. Pract Radiat Oncol. 2017 Jan - Feb; 7(1):e19-e22.
    View in: PubMed
    Score: 0.004
  112. Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors. J Clin Oncol. 2016 Apr 01; 34(10):1043-9.
    View in: PubMed
    Score: 0.004
  113. Mucoepidermoid Carcinoma in Children: A Single Institutional Experience. Pediatr Blood Cancer. 2016 Jan; 63(1):27-31.
    View in: PubMed
    Score: 0.004
  114. Imaging Changes in Pediatric Intracranial Ependymoma Patients Treated With Proton Beam Radiation Therapy Compared to Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):54-63.
    View in: PubMed
    Score: 0.004
  115. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):349-57.
    View in: PubMed
    Score: 0.003
  116. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys. 2014 Oct 01; 90(2):354-61.
    View in: PubMed
    Score: 0.003
  117. Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast. Br J Cancer. 2014 Jul 29; 111(3):619-22.
    View in: PubMed
    Score: 0.003
  118. Long-term outcome of centrally located low-grade glioma in children. Cancer. 2013 Jul 15; 119(14):2630-8.
    View in: PubMed
    Score: 0.003
  119. Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas. Neuro Oncol. 2013 Jun; 15(6):759-66.
    View in: PubMed
    Score: 0.003
  120. Prognostic markers for invasive micropapillary carcinoma of the breast: a population-based analysis. Clin Breast Cancer. 2013 Apr; 13(2):133-9.
    View in: PubMed
    Score: 0.003
  121. Treatment trends and outcomes of small-cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):64-70.
    View in: PubMed
    Score: 0.003
  122. A Surveillance, Epidemiology and End Results (SEER) program comparison of adult and pediatric Wilms' tumor. Cancer. 2012 May 01; 118(9):2541-51.
    View in: PubMed
    Score: 0.003
  123. A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends. Cancer. 2011 Dec 01; 117(23):5325-33.
    View in: PubMed
    Score: 0.003
  124. Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system. Technol Cancer Res Treat. 2009 Dec; 8(6):407-12.
    View in: PubMed
    Score: 0.002
  125. Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):214-21.
    View in: PubMed
    Score: 0.002
  126. Versatility of the Novalis system to deliver image-guided stereotactic body radiation therapy (SBRT) for various anatomical sites. Technol Cancer Res Treat. 2007 Aug; 6(4):347-54.
    View in: PubMed
    Score: 0.002
  127. A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT. J Pediatr Hematol Oncol. 2007 Jul; 29(7):500-5.
    View in: PubMed
    Score: 0.002
  128. What is the best adjuvant treatment for very young patients with medulloblastoma? Expert Rev Neurother. 2007 Apr; 7(4):373-81.
    View in: PubMed
    Score: 0.002
  129. Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response. AJR Am J Roentgenol. 2006 Jul; 187(1):65-72.
    View in: PubMed
    Score: 0.002
  130. Radiation-induced moyamoya syndrome. Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):1222-7.
    View in: PubMed
    Score: 0.002
  131. Scheduling for radiotherapy simulation in children with a renal mass. Pediatr Hematol Oncol. 2006 Apr-May; 23(3):275-6.
    View in: PubMed
    Score: 0.002
  132. Radiation-induced osteosarcomas in the pediatric population. Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63(4):1169-74.
    View in: PubMed
    Score: 0.002
  133. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer. Head Neck. 2005 Jun; 27(6):494-502.
    View in: PubMed
    Score: 0.002
  134. Extra-target doses in children receiving multileaf collimator (MLC) based intensity modulated radiation therapy (IMRT). Pediatr Blood Cancer. 2004 Jun; 42(7):626-30.
    View in: PubMed
    Score: 0.002
  135. The effect of an extended source-to-skin distance in the treatment of the spinal field in children receiving craniospinal irradiation. Med Dosim. 2004; 29(1):7-10.
    View in: PubMed
    Score: 0.002
  136. Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer? Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):230-8.
    View in: PubMed
    Score: 0.002
  137. Locoregional treatment for adult soft tissue sarcomas of the head and neck: an institutional review. Cancer J. 2003 Jan-Feb; 9(1):49-57.
    View in: PubMed
    Score: 0.001
  138. Curative radiotherapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys. 2002 Nov 01; 54(3):818-23.
    View in: PubMed
    Score: 0.001
  139. Prognostic factors in head and neck rhabdomyosarcoma. Head Neck. 2002 May; 24(5):468-73.
    View in: PubMed
    Score: 0.001
  140. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2002 Jan 01; 52(1):14-22.
    View in: PubMed
    Score: 0.001
  141. Esthesioneuroblastoma: the University of Iowa experience 1978-1998. Laryngoscope. 2001 Mar; 111(3):488-93.
    View in: PubMed
    Score: 0.001
  142. Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer. J Magn Reson Imaging. 2000 Dec; 12(6):1027-33.
    View in: PubMed
    Score: 0.001
  143. Magnetic resonance imaging in the assessment of radiation response in cervical cancer: regarding Hatano K et al. IJROBP 1999; 45:399-344. Int J Radiat Oncol Biol Phys. 2000 Oct 01; 48(3):910-2.
    View in: PubMed
    Score: 0.001
  144. Determination of the inferior border of the thecal sac using magnetic resonance imaging: implications on radiation therapy treatment planning. Int J Radiat Oncol Biol Phys. 1998 Jun 01; 41(3):621-4.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.